Brief: Asit Biotech Reviews Efficacy Results Of Gp-Asit+ Observed During The Phase III Trial Completed In 2016

European Medical Solutions SA

14/12/2017 17:09

Dec 14 (Reuters) - ASIT BIOTECH SA  ASIT.BR : 
    * ASIT BIOTECH REVIEWS THE EFFICACY RESULTS OF GP-ASIT+ 
OBSERVED 
DURING THE PHASE III TRIAL COMPLETED IN 2016 
    * OVER COURSE OF POLLEN SEASON, GP-ASIT+() RESULTED IN 
AVERAGE 
REDUCTION IN COMBINED SCORE OF 17.9% FOR STUDY POPULATION 
 
Source text for Eikon:  ID:nBw5sphQja  
Further company coverage:  ASIT.BR  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))